Dichloroacetate attenuates the stemness of colorectal cancer cells via trigerring ferroptosis through sequestering iron in lysosomes

Environ Toxicol. 2021 Apr;36(4):520-529. doi: 10.1002/tox.23057. Epub 2020 Nov 9.

Abstract

Colorectal cancer stem cell (CSC) has been regarded to be the root of colorectal cancer progression. However, there is still no effective therapeutic method targeting colorectal CSC in clinical application. Here, we investigated the effects of dichloroacetate (DCA) on colorectal cancer cell stemness. We showed that DCA could reduce colorectal cancer cell stemness in a dose-dependent manner, which is evident by the decreased expression of stemness markers, tumor cell sphere-formation and cell migration ability. In addition, it was found that DCA trigerred the ferroptosis of colorectal CSC, which is characterized as the upregulation of iron concentration, lipid peroxides, and glutathione level, and decreased cell viability. Mechanistic studies demonstrated that DCA could sequester iron in lysosome and thus trigger ferroptosis, which is necessary for DCA-mediated attenuation on colorectal cancer cell stemness. Taken together, this work suggests that DCA might be a colorectal CSC-killer.

Keywords: cancer stem cell; colorectal cancer; dichloroacetate; ferroptosis; iron.

MeSH terms

  • Cell Movement / drug effects
  • Cell Survival / drug effects
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology*
  • Dichloroacetic Acid / pharmacology*
  • Dose-Response Relationship, Drug
  • Ferroptosis / drug effects*
  • HCT116 Cells
  • HT29 Cells
  • Humans
  • Iron / metabolism*
  • Lysosomes / drug effects*
  • Lysosomes / metabolism
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Sequestering Agents / pharmacology*

Substances

  • Sequestering Agents
  • Dichloroacetic Acid
  • Iron